These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26253090)

  • 1. Comment on: Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
    Grammatico-Guillon L; Gras G; Hassen-Khodja C; Maakaroun Z; Bastides F; Barin F; Bernard L
    J Antimicrob Chemother; 2015 Nov; 70(11):3172-3. PubMed ID: 26253090
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
    Raffi F; Yazdanpanah Y; Fagnani F; Laurendeau C; Lafuma A; Gourmelen J
    J Antimicrob Chemother; 2015 Jul; 70(7):2121-8. PubMed ID: 25904729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".
    Bangsberg DR; Haberer JE
    JAMA Intern Med; 2013 Feb; 173(4):306-7. PubMed ID: 23358810
    [No Abstract]   [Full Text] [Related]  

  • 4. Better adherence with once-daily antiretroviral regimens: a meta-analysis.
    Parienti JJ; Bangsberg DR; Verdon R; Gardner EM
    Clin Infect Dis; 2009 Feb; 48(4):484-8. PubMed ID: 19140758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does managed problem solving work and in what setting?
    de Bruin M
    JAMA Intern Med; 2013 Aug; 173(15):1474. PubMed ID: 23939522
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quest for an effective adherence intervention: a DOT-cART case study.
    Athey E
    J Assoc Nurses AIDS Care; 2014; 25(6):682-6. PubMed ID: 25305032
    [No Abstract]   [Full Text] [Related]  

  • 8. Securing opioid substitution treatment access and quality for people who inject drugs.
    Carrieri MP; Sagaon-Teyssier L; Roux P
    AIDS; 2015 May; 29(8):975-6. PubMed ID: 25909829
    [No Abstract]   [Full Text] [Related]  

  • 9. Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.
    Cornell M; Grimsrud A; Boulle A; Myer L
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e102; author reply e102-3. PubMed ID: 21317578
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.
    Marcellin F; Spire B; Carrieri MP; Roux P
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):239-50. PubMed ID: 23458765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
    Sutton SS; Magagnoli J; Hardin JW
    Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks.
    Sutton SS; Hardin JW; Bramley TJ; D'Souza AO; Bennett CL
    Am J Manag Care; 2016 Apr; 22(4):242-8. PubMed ID: 27143289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fixed dose combinations and single tablet regimen for HIV therapy].
    Esser S
    MMW Fortschr Med; 2012 May; 154 Suppl 1():17-9. PubMed ID: 22916592
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply: To PMID 23358784.
    Gross R; Bellamy SL; Strom BL
    JAMA Intern Med; 2013 Aug; 173(15):1475-6. PubMed ID: 23939524
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.
    Duncombe C; Kerr SJ; Liddy J; Avihingsanon A; Ruxrungtham K; Phanuphak P
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e19-20. PubMed ID: 20647825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Simplification of antiviral therapy with single tablet regimens: advantages and disadvantages of modern ART].
    Spinner CD
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():29-32. PubMed ID: 25026854
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis.
    Cooke CE; Lee HY; Xing S
    J Manag Care Pharm; 2014 Jan; 20(1):86-92. PubMed ID: 24372462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy.
    Jiménez-Galán R; Cantudo Cuenca MR; Robustillo-Cortés MA; Borrego Izquierdo Y; Almeida-Gonzalez CV; Morillo-Verdugo R
    Farm Hosp; 2016 Jun; 40(4):272-8. PubMed ID: 27571495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking care of the caretakers to enhance antiretroviral adherence in HIV-infected children and adolescents.
    Bryson Y
    J Pediatr (Rio J); 2014; 90(6):533-5. PubMed ID: 25128224
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of treatment adherence in HIV.
    Schaecher KL
    Am J Manag Care; 2013 Sep; 19(12 Suppl):s231-7. PubMed ID: 24495293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.